Clinical Trials Browser

Recruiting × Meningioma × pembrolizumab × Clear all

NCT04659811 2025-04-17

Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

Phase 2 Recruiting

Meningioma

NCT06640582 2024-11-05

BAH2472

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma